[1] TANABE K, TAURA K, KOYAMA Y, et al. Migration of splenic lymphocytes promotes liver fibrosis through modification of T helper cytokine balance in mice[J]. J Gastroenterol, 2015,50(10):1054-1068.
[2] BAO Z, ZHANG Q, WAN H, et al. Expression of suppressor of cytokine signaling 1 in the peripheral blood of patients with idiopathic pulmonaryfibrosis[J]. Chin Med J(中华医学杂志英文版), 2014,127(11):2117-2120.
[3] CHEN L Y, JIN H H, CHEN Q, et al. Progress of sphingosine-1-phosphate in the pathogenesis of liver fibrosis[J]. Chin Pharm J(中国药学杂志), 2014,49(15):1281-1284.
[4] ECHEVERRA C, MONTORFANO I, HERMOSILLA T, et al. Endotoxin induces fibrosis in vascular endothelial cells through a mechanism dependent on transient receptor protein melastatin 7 activity[J]. PLoS One, 2014,9(4): e94146.
[5] GARRATT L W, SUTANTO E N, LING K M, et al. Matrix metalloproteinase activation by free neutrophil elastase contributes to bronchiectasis progression in early cystic fibrosis[J]. Eur Respir J, 2015,46(2):384-394.
[6] SONG Y, ZHAN L, YU M, et al. TRPV4 channel inhibits TGF-β1-induced proliferation of hepatic stellate cells[J]. PLoS One, 2014,9(7): e101179.
[7] ZHAN L, YANG Y, MA T T, et al. Transient receptor potential vanilloid 4 inhibits rat HSC-T6 apoptosis through induction of autophagy[J]. Mol Cell Biochem, 2015,402(1-2):9-22.
[8] RAHAMAN S O, GROVE L M, SOUTHERN B D, et al. Role of cation channel TRPV4 in mechanosensing, myofibroblast differentiation, and pulmonary fibrosis[J]. Ann Am Thorac Soc,2015,12(suppl 1):74-75.
[9] YANG M, ZHENG J, MIAO Y, et al. Serum-glucocorticoid regulated kinase 1 regulates alternatively activated macrophage polarization contributing to angiotensin II-induced inflammation and cardiac fibrosis[J]. Arterioscler Thromb Vasc Biol, 2012,32(7):1675-1686.
[10] FUSI C, MATERAZZI S, MINOCCI D, et al. Transient receptor potential vanilloid 4 (TRPV4) is downregulated in keratinocytes in human non-melanoma skin cancer[J]. J Invest Dermatol, 2014,134(9):2408-2417.
[11] LIEDTKE W, CHOE Y, MARTí-RENOM M A, et al. Vanilloid receptor-related osmotically activated channel (VR-OAC), a candidate vertebrate osmoreceptor[J]. Cell, 2000,103(3):525-535.
[12] SHIGEMATSU H, SOKABE T, DANEV R, et al. A 3.5-nm structure of rat TRPV4 cation channel revealed by zernike phase-contrast cryoelectron microscopy[J]. J Biol Chem, 2010,285(15):11210-11218.
[13] DUNN K M, HILL-EUBANKS D C, LIEDTKE W B, et al. TRPV4 channels stimulate Ca²⁺-induced Ca²⁺ release in astrocytic endfeet and amplify neurovascular coupling responses[J]. Proc Natl Acad Sci USA, 2013,110(15):6157-6162.
[14] EVERAERTS W, NILIUS B, OWSIANIK G. The vanilloid transient receptor potential channel TRPV4: From structure to disease[J]. Prog Biophys Mol Biol, 2010,103(1):2-17.
[15] SHI M, DU F, LIU Y, et al. Glial cell-expressed mechanosensitive channel TRPV4 mediates infrasound-induced neuronal impairment[J]. Acta Neuropathol, 2013,126(5):725-739.
[16] GOSWAMI C, KUHN J, HEPPENSTALL P A, et al. Importance of non-selective cation channel TRPV4 interaction with cytoskeleton and their reciprocal regulationsin cultured cells[J]. PLoS One, 2010,5(7):e11654.
[17] SHIN S H, LEE E J, HYUN S, et al. Phosphorylation on the Ser 824 residue of TRPV4 prefers to bind with F-actin than with microtubules to expand the cell surface area[J]. Cell Signal, 2012,24(3):641-651.
[18] LEE E J, SHIN S H, HYUN S, et al. Mutation of a putative S-nitrosylation site of TRPV4 protein facilitates the channel activates[J]. Animal Cells Syst (Seoul), 2011,15(2):95-106.
[19] FENG S, RODAT-DESPOIX L, DELMAS P, et al. A single amino acid residue constitutes the third dimerization domain essential for the assembly and function of the tetrameric polycystin-2 (TRPP2) channel[J]. J Biol Chem, 2011,286(21):18994-19000.
[20] CENI E, MELLO T, GALLI A. Pathogenesis of alcoholic liver disease: Role of oxidative metabolism[J]. World J Gastroenterol, 2014,20(47):17756-17772.
[21] LU C F, WU X F, LIAN N Q, et al. Research progress in role and mechanism of endogenous cannabinoid system in hepatic disease[J]. Chin Pharm J(中国药学杂志), 2014,49(2):89-93.
[22] ZHANG X, HAN X, YIN L, et al. Potent effects of dioscin against liver fibrosis[J]. Sci Rep, 2015,5:9713.
[23] HE Y, HUANG C, SUN X, et al. MicroRNA-146a modulates TGF-beta1-induced hepatic stellate cell proliferation by targeting SMAD4[J]. Cell Signal, 2012,24(10):1923-1930.
[24] CUSHING L, KUANG P, L J. The role of miR-29 in pulmonary fibrosis[J]. Biochem Cell Biol, 2015,93(2):109-118.
[25] RYAN J J, HUSTON J, KUTTY S, et al. Right ventricular adaptation and failure in pulmonary arterial hypertension[J]. Can J Cardiol, 2015,31(4):391-406.
[26] RAGHU G, COLLARD H R, EGAN J J, et al. An official ATS/ERS/JRS/ALAT statement:Idiopathic pulmonary fibrosis: Evidence-based guidelines for diagnosis and management[J]. Am J Respir Crit Care Med, 2011,183(6):788-824.
[27] LEY B, COLLARD H R. Epidemiology of idiopathic pulmonary fibrosis[J]. Clin Epidemiol, 2013,5:483-492.
[28] RAHAMAN S O, GROVE L M, SOUTHERN B D, et al. Role of cation TRPV4 in mechanosensing, myofibroblast differentiation, and pulmonary fibrosis[J]. Ann Am Thorac Soc, 2015,12(suppl 1):74-75.
[29] RAHAMAN S O, GROVE L M, PARUCHURI S, et al. TRPV4 Mediates myofibroblast differentiation and pulmonary fibrosis in mice[J]. J Clin Invest, 2014,124(12):5225-5238.
[30] VINCENT F, DUNCTON M A. TRPV4 Agonists and antagonists[J]. Curr Top Med Chem, 2011,11(17):2216-2226.
[31] SEMINARIO-VIDAL L, OKADA S F, SESMA J I, et al. Rho signaling regulates pannexin 1-mediated ATP release from airway epithelia[J]. J Biol Chem, 2011,286(30):26277-26286.
[32] DING X L, WANG Y H, NING L P, et al. Involvement of TRPV4-NO-cGMP-PKG pathways in the development of thermal hyperalgesia following chronic compression of the dorsal root ganglion in rats[J]. Behav Brain Res, 2010,208(1):194-201.
[33] SUN M, CHEN M, DAWOOD F, et al. Tumor necrosis factor-alpha mediates cardiac remodeling and ventricular dysfunction after pressure overload state[J]. Circulation, 2007,115(11):1398-1407.
[34] LANG F, STOURNARAS C, ALESUTAN I. Regulation of transport across cell membranes by the serum- and glucocorticoid-inducible kinase SGK1[J]. Mol Membr Biol, 2014,31(1):29-36.
[35] GRAND T, SALVARANI N, JOUSSET F, et al. Aggravation of cardiac myofibroblast arrhythmogeneicity by mechanical stress[J]. Cardiovasc Res, 2014,104(3):489-500.
[36] STROTMANN R, HARTENECK C, NUNNENMACHER K, et al. OTRPC4, a nonselective cation channel that confers sensitivity to extracellular osmolarity[J]. Nat Cell Biol, 2000,2(10):695-702.
[37] INOUE R, JENSEN L J, SHI J, et al. Transient receptor potential channels in cardiovascular function and disease[J]. Circ Res, 2006,99(2):119-131.
[38] ZHAO L, SULLIVAN M N, CHASE M, et al. Calcineurin/nuclear factor of activated T cells-coupled vanilliod transient receptor potential channel 4 Ca²⁺ sparklets stimulate airway smooth muscle cell proliferation[J]. Am J Respir Cell Mol Biol, 2014,50(6):1064-1075.
[39] YANG M, ZHENG J, MIAO Y, et al. Serum-glucocorticoid regulated kinase 1 regulates alternatively activated macrophage polarization contributing to angiotensin II-induced inflammation and cardiac fibrosis[J]. Arterioscler Thromb Vasc Biol, 2012,32(7):1675-1686.
[40] QU X, ZHANG X, YAO J, et al. Resolvins E1 and D1 inhibit interstitial fibrosis in the obstructed kidney via inhibition of local fibroblast proliferation[J]. J Pathol, 2012,228(4):506-519.
[41] LANG F, VOELKL J. Therapeutic potential of serum and glucocorticoid inducible kinase inhibition[J]. Expert Opin Investig Drugs, 2013,22(6):701-714.
[42] SARKZI R, HAUSER C, NOPPERT S J, et al. Oncostatin M is a novel inhibitor of TGF-β1-induced matricellular protein expression[J]. Am J Physiol Renal Physiol, 2011,301(5):1014-1025.
[43] ZHONG J, ZHAO N B. Pathogenesis and differentiation of renal fibrosis collateral disease[J].J Nanjing Univ Tradit Chin Med(南京中医药大学学报), 2014,30(6):510-512.
[44] SALIBA Y, KARAM R, SMAYRA V, et al. Evidence of a role for fibroblast transient receptor potential canonical 3 Ca²⁺ channel in renal fibrosis[J]. J Am Soc Nephrol, 2014,26(8):1855-1876.
[45] WANG Y, WANG D H. Protective effect of TRPV1 against renal fibrosis via inhibition of TGF-β/Smad signaling in DOCA-salt hypertension[J]. Mol Med, 2011,17(11-12):1204-1212.